The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 20, 2018

Filed:

Dec. 16, 2016
Applicants:

The Regents of the University of California, Oakland, CA (US);

The Research Foundation for the State University of New York, Albany, NY (US);

Inventors:

Jose Manuel Mejia Oneto, Oakland, CA (US);

Maksim Royzen, Albany, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/06 (2006.01); A61K 38/14 (2006.01); C07D 257/08 (2006.01); A61K 47/48 (2006.01); A61K 49/00 (2006.01); A61K 51/04 (2006.01); C07D 311/82 (2006.01); C07D 499/74 (2006.01); C07H 7/02 (2006.01); C07H 15/24 (2006.01); C07H 19/167 (2006.01); C07H 19/213 (2006.01); A61K 31/43 (2006.01); A61K 31/7076 (2006.01); A61K 38/12 (2006.01); A61K 51/12 (2006.01);
U.S. Cl.
CPC ...
A61K 51/065 (2013.01); A61K 31/43 (2013.01); A61K 31/7076 (2013.01); A61K 38/12 (2013.01); A61K 38/14 (2013.01); A61K 47/4823 (2013.01); A61K 47/48023 (2013.01); A61K 47/48038 (2013.01); A61K 47/48061 (2013.01); A61K 47/48353 (2013.01); A61K 47/48784 (2013.01); A61K 49/0041 (2013.01); A61K 49/0043 (2013.01); A61K 49/0052 (2013.01); A61K 49/0054 (2013.01); A61K 49/0073 (2013.01); A61K 51/0482 (2013.01); A61K 51/0495 (2013.01); A61K 51/1213 (2013.01); C07D 257/08 (2013.01); C07D 311/82 (2013.01); C07D 499/74 (2013.01); C07H 7/02 (2013.01); C07H 15/24 (2013.01); C07H 19/167 (2013.01); C07H 19/213 (2013.01);
Abstract

The present invention provides a method for selective delivery of a therapeutic or diagnostic agent to a targeted organ or tissue by implanting a biocompatible solid support in the patient being linked to a first binding agent, and administering a second binding agent to the patient linked to the therapeutic or diagnostic agent, such that the therapeutic or diagnostic agent accumulates at the targeted organ or tissue.


Find Patent Forward Citations

Loading…